Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement | Zendy

Yigal Abramowitz | Zendy; Sreekanth Vemulapalli | Zendy; Tarun Chakravarty | Zendy; Zhuokai Li | Zendy; Samir Kapadia | Zendy; David R. Holmes | Zendy; Roland Matsouaka | Zendy; Alice Wang | Zendy; Wen Cheng | Zendy; James S. Forrester | Zendy; Richard W. Smalling | Zendy; Vinod H. Thourani | Zendy; Michael J. Mack | Zendy; Martin B. Leon | Zendy; Raj Makkar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement

Author(s) -

Yigal Abramowitz,

Sreekanth Vemulapalli,

Tarun Chakravarty,

Zhuokai Li,

Samir Kapadia,

David R. Holmes,

Roland Matsouaka,

Alice Wang,

Wen Cheng,

James S. Forrester,

Richard W. Smalling,

Vinod H. Thourani,

Michael J. Mack,

Martin B. Leon,

Raj Makkar

Publication year - 2017

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.117.005417

Subject(s) - medicine , hazard ratio , diabetes mellitus , confidence interval , valve replacement , cardiology , proportional hazards model , surgery , endocrinology , stenosis

Diabetes mellitus (DM) adversely affects morbidity and mortality for cardiovascular diseases and procedures. Data evaluating the outcomes of transcatheter aortic valve replacement (TAVR) in diabetic patients are limited by small sample size and contradictory results. We aimed to establish the magnitude of risk and the incremental influence of insulin dependency by examining short- and long-term adverse outcomes according to DM status and therapy in the world's largest TAVR registry.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research